The Justice Department and the U.S. Drug Enforcement Administration (DEA) announced on June 18 a 10-count superseding indictment, charging Los Angeles-based individuals linked to Mexico’s Sinaloa drug cartel with conspiring with money-laundering groups linked to a Chinese underground banking network in order to launder drug trafficking proceeds. Cartel members linked to Mexico used a Chinese… Keep Reading
The Drug Enforcement Administration (DEA) recently released a report on May 9 with details about its 2024 National Drug Threat Assessment (NDTA), which is dedicated to compiling data in relation to illegal drugs and trafficking trends within the U.S. DEA Administrator Anne Milgram introduced the report to warn of the many threats to public safety… Keep Reading
A new report from the Arkansas Department of Finance and Administration (DFA) shares a variety of facts about the state’s medical cannabis program, which launched in May 2019. According to the Arkansas Advocate, dozens of storefronts have opened over the past five years, and an estimated 102,000 medical cannabis patient cardholders have approved. In total… Keep Reading
Last week, the Drug Enforcement Administration (DEA) shared that marijuana would be rescheduled from a Schedule I, meaning that the plant was classified as a substance with no accepted medical value, such as heroin, to a Schedule III, controlled substances that allow for some medical use, such as ketamine. While cannabis advocates, stoners, and anyone… Keep Reading
The U.S. Drug Enforcement Administration (DEA), under the Biden administration, will move to reclassify cannabis under Schedule III, meaning its medical benefits will be recognized by the federal government, the Associated Press first reported today. By all accounts, it’s a historic move by the DEA and the federal government as the plant was wrongly classified… Keep Reading
